Related Experiment Videos

Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis

G Marenzi1, G Lauri, M Guazzi

  • 1IRCCS, Institute of Cardiology, University of Milan, Italy. giancarlo.marenzi@cardiologicomonzino.it

Insights

In chronic heart failure, both cardiac and renal dysfunction significantly contribute to neurohumoral activation. This activation is closely linked to reduced long-term survival in patients with heart failure.

Area of Science:

  • Cardiology
  • Nephrology
  • Neuroendocrinology

Background:

  • Cardiac dysfunction is a known driver of neurohumoral activation in chronic heart failure (CHF).
  • The specific contribution of renal impairment to neurohumoral activation in CHF remains less defined.
  • This study aimed to clarify the interplay between cardiac and renal function and neurohumoral status in CHF patients.

Purpose of the Study:

  • To investigate the relationship between cardiac dysfunction, renal impairment, and neurohumoral activation in CHF patients.
  • To assess the impact of these factors on long-term prognosis and survival.

Main Methods:

  • Evaluated hemodynamics, renal function (serum creatinine), and plasma neurohormones in 148 CHF patients.
  • Patients were categorized into four groups based on systolic volume index (cardiac function) and serum creatinine levels (renal function).
  • Long-term follow-up data was collected to assess survival rates.

Main Results:

  • Neurohormone levels progressively increased across the four patient groups, correlating with both cardiac and renal dysfunction.
  • Patients with renal dysfunction exhibited markedly increased neurohormones compared to those with normal renal function.
  • Long-term survival progressively decreased from Group I to IV, with significantly poorer outcomes in patients presenting with renal dysfunction.

Conclusions:

  • Neurohumoral activation in CHF is strongly associated with long-term survival.
  • Both cardiac and renal dysfunction play significant roles in the development and progression of neurohumoral activation.
  • Renal dysfunction is a critical factor influencing prognosis in CHF patients.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...